Wamberg Genomic Advisors, a company involved in genomic testing, has named David Stertzer as its new managing director, it was reported yesterday.
Stertzer is the immediate past CEO and current advisor of AALU, an organisation involved in life insurance and annuities distribution in Washington, DC As the top officer at AALU for nearly thirty-three years, Stertzer is claimed to have provided continuity, leadership and strategic vision to AALU's board of directors.
In the new role, Stertzer will advise life insurance companies on genomic and advanced DNA program strategies.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer